Please assess the completion status of the following clinical trial:

Trial Title: The Diurnal Rhythm in Natriuretic Peptide Levels

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 to 40 years~* Blood pressure less than 140/90~* Body Mass Index between 18.5 to 25 kg/m2 (lean) or 30 to 45 kg/m2 (obese)~* Self identified African-American or white individuals~* Willingness to comply with the study diet~* Provide informed consent~Exclusion Criteria:~* History of hypertension~* History of cardiovascular, renal, or liver disease~* Diabetes or use of glucose-lowering medications~* Use of vasoactive or diuretic medications~* Atrial fibrillation~* Anemia (Hematocrit \<41%)~* Abnormal serum sodium or potassium~* Abnormal liver function tests (\>3x upper limit of normal)~* Current smokers~* Regular users of non-steroid anti-inflammatory medications

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Study Individuals (Type: OTHER): Healthy self-identified African-American and white male participants will be screened. Study consent will be obtained, medical history and physical examination administered, and study eligibility determined based on the inclusion and exclusion criteria. Eligible subjects will meet a bio-nutritionist who will explain the 5 days of standardized diet at the screening visit and will review instructions for complying with the diet. If the subject agrees to adhere to the study diet, they will then be enrolled in the study (stratified by race).

Based on this trial design, predict the completion outcome and termination type (if applicable).